All News
Corporate

2022: The year of acceleration

Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Analgesic with a Range of Therapeutic Applications

DoubleRainbow Biosciences Announces Strategic AI Collaboration with Galixir
Double Rainbow Announces Membership with BioMADE

DoubleRainbow Biosciences and Kelai Pharmaceuticals to collaborate on novel natural compound therapeutics

2021: A year in Review
